Physician profile
Van Sanderfer
NPI 1841827813
$3,033.04
in general payments reported to CMS, 2019-2025
11 companies · $723 in 2025
The $723 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2023: $843 · 2024: $1,342 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,898 · Gift: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,897.52 |
| Gift | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $689.36 | 2021-2025 | Advantagerib |
| Davol INC. | $576.47 | 2023-2025 | Phasix Mesh, Progel Applicator Spray Tips, Arista Ah Flexitip |
| Teleflex LLC | $426.98 | 2023-2025 | Quikclot, Quikclot, Arrow |
| Stryker Corporation | $306.07 | 2023-2025 | Spy-Phi System |
| Integra Lifesciences Corporation | $234.71 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Innovation Technologies INC | $162.66 | 2023 | Irrisept |
| Acera Surgical, INC. | $161.86 | 2024 | Restrata Wound Matrix |
| Intuitive Surgical, INC. | $150.05 | 2023-2025 | Da Vinci Surgical System |
| Biotissue Holdings INC. | $149.76 | 2024 | |
| Aroa Biosurgery Incorporated | $123.07 | 2024 | |
| Conmed Corporation | $52.05 | 2023 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Sanderfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.